Dr Bruce L A Carter is an affiliate Professor of Biochemistry at the University of Washington USA. He was the Chairman of the Board and former Chief Executive Officer of ZymoGenetics Inc., USA. He has also served as the Corporate Executive Vice President and Chief Scientific Officer for Novo Nordisk A/S, the former parent company of ZymoGenetics. From 1982 to 1986 Dr. Carter held various positions of increasing responsibility at G.D. Searle & Co., Limited, including Head of Molecular Genetics. He was a lecturer at Trinity College, University of Dublin, from 1975 to 1982. Dr. Carter holds directorship in Enanta Pharmaceutical Inc., Mirati Therapeutics Inc., and TB Alliance, all in the US and our wholly-owned subsidiary, Aurigene Discovery Technologies Limited, in India and our wholly-owned subsidiary, Dr. Reddy’s Laboratories Inc., in US. Dr. Carter received a B.Sc. with Honors in Botany from the University of Nottingham, England and a Ph.D. in Microbiology from Queen Elizabeth College, London University, UK.